Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
extension tags : Research save search
Global Oil & Gas Pipeline Market Size to Reach USD 53.54 Billion by 2030, Registering a CAGR of 6.50%, with North America Leading the Market Due to Established Extensive Pipeline Network, Projects Kings Research
Published: 2024-01-24 (Crawled : 12:00) - prnewswire.com
FTI | $25.16 -0.71% -0.6% 3M
|
Industrial Services
|
| O: 0.92%
H: 0.89%
C: 0.1%
COP | News M | $127.81 -0.41% -0.47% 3.6M
|
Energy Minerals
|
| O: 0.86%
H: 1.01%
C: 0.69%
CVX | News | $157.57 0.75% -0.05% 5M
|
Energy Minerals
|
| O: 0.43%
H: 1.6%
C: 1.56%
america reach gas pipeline research global oil market
Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research
Published: 2023-10-12 (Crawled : 13:00) - biospace.com/
VRPX | $3.87 11.53% 10.34% 20K
|
|
| O: 0.0%
H: 5.13%
C: 5.1%
institute virpax pharmaceuticals research extension
Incyte Announces Positive 52-Week Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nonsegmental Vitiligo
Published: 2023-10-11 (Crawled : 13:00) - biospace.com/
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.45%
H: 0.52%
C: -0.94%
incb5470 positive study
Bright Green announces plans to launch a program to support as many as 170 universities for cannabis research in the United States as well as an extension of the Company’s EB-5 initiative to enable foreign students attending universities in the United States to access EB-5 visas
Published: 2023-07-17 (Crawled : 13:00) - globenewswire.com
BGXX | $0.2299 5.46% 5.18% 420K
|
|
| O: 1.51%
H: 1.63%
C: -4.22%
cannabis research extension program
Protagonist Therapeutics Plans a Follow-on Two-Year Extension Study to Enable Further Evaluation of the Long-Term Effects of Rusfertide
Published: 2023-06-09 (Crawled : 14:00) - biospace.com/
PTGX | $25.23 -1.33% -1.35% 390K
|
Health Technology
|
| O: 0.48%
H: 0.2%
C: -1.39%
extension therapeutics study
Bionano Announces Extensive Lineup of Content at European Conferences Featuring OGM Utility Across a Broad Range of Research Applications
Published: 2023-06-08 (Crawled : 12:00) - globenewswire.com
BNGO | $0.7801 -4.38% -4.58% 2.4M
|
Health Technology
|
| O: 0.57%
H: 5.21%
C: -3.96%
research
Merck to Present Extensive New Research Demonstrating Significant Progress in the Treatment of Certain Earlier Stage Cancers and in Advancing Broad Oncology Pipeline at 2023 ASCO Annual Meeting
Published: 2023-05-15 (Crawled : 12:00) - biospace.com/
MRK | $125.23 -0.11% 0.0% 6M
|
Health Technology
|
| O: 0.0%
H: 0.51%
C: -0.66%
merck asco pipeline treatment research meeting
NLS Pharmaceutics Announces Open Label Extension Study Six-Month Data for Quilience(R) (Mazindol ER) in the Treatment of Narcolepsy Type 1 and Type 2
Published: 2023-03-27 (Crawled : 13:00) - biospace.com/
NLSP | $0.133 6.04% 96K
|
|
| O: 1.39%
H: 16.41%
C: 6.25%
label narcolepsy treatment extension study
NLS Pharmaceutics Announces Completion of Open Label Extension Study with Quilience(R) (Mazindol ER) for the Treatment of Narcolepsy
Published: 2023-01-30 (Crawled : 15:00) - biospace.com/
NLSP | $0.133 6.04% 96K
|
|
| O: 2.6%
H: 2.07%
C: -3.45%
treatment label extension narcolepsy study
Bionano Genomics Announces Extensive Lineup of Content at Association for Molecular Pathology (AMP) Annual Meeting Featuring OGM Utility Across Broad Range of Research Applications
Published: 2022-10-28 (Crawled : 12:20) - globenewswire.com
BNGO | $0.7801 -4.38% -4.58% 2.4M
|
Health Technology
|
| O: 3.04%
H: 4.09%
C: 3.64%
research meeting genomics molecular
FDA Authorizes an Extension of the In-Use Period for UroGen Pharma’s JELMYTO® Admixture to 96 Hours Following Reconstitution
Published: 2022-09-28 (Crawled : 13:00) - biospace.com/
URGN | $14.32 0.56% 0.56% 320K
|
Health Technology
|
| O: 1.99%
H: 9.99%
C: 5.48%
jelmyto fda extension
Avidity Biosciences Enrolls Patients in the MARINA™ Open-Label Extension Study
Published: 2022-08-02 (Crawled : 14:00) - biospace.com/
RNA | $23.04 -2.17% -2.21% 1.1M
|
Health Technology
|
| O: -0.58%
H: 7.34%
C: 6.57%
extension study
SeaSpine Announces Three-Year Extension and Expansion of $30 Million Credit FacilityProvides for up to an additional $10 million of liquidity
Published: 2022-07-19 (Crawled : 00:00) - biospace.com/
SPNE | $9.54 8.29% -1.99%
|
Health Technology
|
| O: 5.21%
H: 0.0%
C: 0.0%
expansion extension seaspine
Cytokinetics Announces Start of Open-Label Extension Study for Patients Completing COURAGE-ALSManaged Access Program for People Who Have Completed Prior Cytokinetics ALS Trials to Begin in 2H 2022
Published: 2022-06-16 (Crawled : 14:00) - biospace.com/
CYTK | $67.0 -1.37% -1.39% 890K
|
Health Technology
|
| O: -2.48%
H: 0.0%
C: 0.0%
trials extension als program
Lipocine Announces Positive LPCN 1144 NASH Open Label Extension Study Results
Published: 2022-05-12 (Crawled : 13:00) - biospace.com/
LPCN | $5.47 2.82% 2.74% 21K
|
Health Technology
|
| O: -5.19%
H: 2.7%
C: 0.26%
label positive results nash
Athira Pharma Extends Ongoing Open Label Extension Study for LIFT-AD and ACT-AD Clinical Trials of Fosgonimeton (ATH-1017) for Mild to Moderate Alzheimer’s Disease
Published: 2022-05-09 (Crawled : 12:20) - biospace.com/
ATHA | $2.07 -1.9% -1.93% 200K
|
Health Technology
|
| O: -10.47%
H: 3.1%
C: -2.0%
ath-1017 ongoing pharma trials label disease alzheimer’s alzheimer's fosgonimeton
Tonix Pharmaceuticals Announces Extension of Sponsored Research Agreement with Kansas State University to Develop Live-Virus Vaccine Against COVID-19
Published: 2022-04-05 (Crawled : 08:00) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: -5.23%
covid-19 research vaccine state
Sio Gene Therapies Announces Prioritization of Lead Gene Therapy Programs in GM1 and GM2 Gangliosidosis, Extension of Cash Runway, and CEO Transition
Published: 2022-01-31 (Crawled : 23:00) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: -1.87%
H: 14.29%
C: 11.43%
gene therapy program ceo gene therapies therapy
23andMe Announces Extension of GSK Collaboration and Update on Joint Immuno-oncology Program
Published: 2022-01-18 (Crawled : 23:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.8%
H: 6.54%
C: 6.21%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 2.34%
H: 0.0%
C: 0.0%
collaboration
Liver Cancer Patient Treated with Can-Fite’s Namodenoson Clears All Cancer Lesions Under Open Label Extension of Phase II Study
Published: 2021-12-20 (Crawled : 12:30) - biospace.com/
CANF | $2.02 3.06% -2.48% 10K
|
Health Technology
|
| O: 88.98%
H: 8.33%
C: -10.42%
liver cancer namodenoson
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.